Trials / Terminated
TerminatedNCT04209530
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
A Phase 2a, Open Label Study to Assess the Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Females Using Photonumeric Scales, Magnetic Resonance Imaging and Histopathology
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, open-label, Phase 2a study to assess the photonumeric scale, morphological, and histopathological changes associated with Collagenase Clostridium Histolyticum (CCH) in adult women with moderate or severe Edematous Fibrosclerotic Panniculopathy (EFP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EN3835 | Collagenase Clostridium Histolyticum (CCH) |
Timeline
- Start date
- 2019-11-20
- Primary completion
- 2020-07-23
- Completion
- 2020-10-05
- First posted
- 2019-12-24
- Last updated
- 2021-10-07
- Results posted
- 2021-10-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04209530. Inclusion in this directory is not an endorsement.